Patent ID: 11945834
Assignee: BRISTOL-MYERS SQUIBB COMPANY
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 14:
15. A compound according to claim 1 which is
4-[(1R,6R,8R,9R,10R,15R,17S,18R)-8-(6-amino-9H-purin-9-yl)-9-fluoro-18-hydroxy-3,12-dioxo-3,12-disulfanyl-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]pyridine-2-carboxamide,
4-[(1R,6R,8R,9R,10R,15R,17S,18R)-8-(6-amino-9H-purin-9-yl)-9-fluoro-18-hydroxy-3,12-dioxo-3,12-disulfanyl-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphospha tricyclo[13.2.1.06,10]octadecan-17-yl]-N-methylpyridine-2-carboxamide, or
4-[(1R,6R,8R,9R,10R,15S,17S)-8-(6-amino-9H-purin-9-yl)-9-fluoro-18-methylidene-3,12-dioxo-3,12-disulfanyl-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]pyridine-2-carboxamide,
4-[(1S,6R,8R,9R,10R,15R,17S,18R)-8-(6-amino-9H-purin-9-yl)-9,18-difluoro-3,12-dioxo-3,12-disulfanyl-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo [13.2.1.06,10]octadecan-17-yl]pyridine-2-carboxamide,
4-[(1R,6R,8R,9R,10R,15R,17S,18R)-9-fluoro-18-hydroxy-8-{3H-imidazo[2,1-f]purin-3-yl}-3,12-dioxo-3,12-disulfanyl-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,1° ]octadecan-17-yl]pyridine-2-carboxamide
or a pharmaceutically acceptable salt thereof.